These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27490764)

  • 1. The p16-Ki-67-HMB45 Immunohistochemistry Scoring System is Highly Concordant With the Fluorescent In Situ Hybridization Test to Differentiate Between Melanocytic Nevi and Melanomas.
    Uguen A; Uguen M; Guibourg B; Talagas M; Marcorelles P; De Braekeleer M
    Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):361-367. PubMed ID: 27490764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A p16-Ki-67-HMB45 immunohistochemistry scoring system as an ancillary diagnostic tool in the diagnosis of melanoma.
    Uguen A; Talagas M; Costa S; Duigou S; Bouvier S; De Braekeleer M; Marcorelles P
    Diagn Pathol; 2015 Oct; 10():195. PubMed ID: 26503349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Diagnostic Algorithm Combining Immunohistochemistry and Molecular Cytogenetics to Diagnose Challenging Melanocytic Tumors.
    Redon S; Guibourg B; Talagas M; Marcorelles P; Uguen A
    Appl Immunohistochem Mol Morphol; 2018; 26(10):714-720. PubMed ID: 28362709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of p16-Ki-67-HMB45 score in sorting benign from malignant Spitz tumors.
    Garola R; Singh V
    Pathol Res Pract; 2019 Oct; 215(10):152550. PubMed ID: 31351802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjunctival nevi and melanoma: multiparametric immunohistochemical analysis, including p16, SOX10, HMB45, and Ki-67.
    Milman T; Zhang Q; Ang S; Elder D; Ida CM; Salomao DR; Lally SE; Shields JA; Hamershock RA; Sioufi K; Shields CL; Eagle RC
    Hum Pathol; 2020 Sep; 103():107-119. PubMed ID: 32707054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reevaluation of established and new criteria in differential diagnosis of Spitz nevus and melanoma.
    Ritter A; Tronnier M; Vaske B; Mitteldorf C
    Arch Dermatol Res; 2018 May; 310(4):329-342. PubMed ID: 29417221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical double stains against Ki67/MART1 and HMB45/MITF: promising diagnostic tools in melanocytic lesions.
    Nielsen PS; Riber-Hansen R; Steiniche T
    Am J Dermatopathol; 2011 Jun; 33(4):361-70. PubMed ID: 21610457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors.
    Al-Rohil RN; Curry JL; Torres-Cabala CA; Nagarajan P; Ivan D; Aung PP; Lyons GF; Bassett RL; Prieto VG; Tetzlaff MT
    Hum Pathol; 2016 Jul; 53():73-81. PubMed ID: 27004944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential diagnostic utility of PRAME and p16 immunohistochemistry in melanocytic nevi and malignant melanoma.
    Bahmad HF; Oh KS; Alexis J
    J Cutan Pathol; 2023 Aug; 50(8):763-772. PubMed ID: 37114299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi.
    Gerami P; Beilfuss B; Haghighat Z; Fang Y; Jhanwar S; Busam KJ
    J Cutan Pathol; 2011 Apr; 38(4):329-34. PubMed ID: 21323721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRAME expression by immunohistochemistry and reverse transcription quantitative PCR in conjunctival melanocytic lesions-a comprehensive clinicopathologic study of 202 cases and correlation of cytogenetics with PRAME expression in challenging conjunctival melanocytic lesions.
    Mudhar HS; Milman T; Stevenson S; Watson M; Kim J; Magan T; Salvi SM; Harley U; Lally SE; Shields CL
    Hum Pathol; 2023 Apr; 134():1-18. PubMed ID: 36804828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of p16 immunohistochemical stain to help differentiate inflamed melanocytic nevi from metastatic melanoma in the setting of immunotherapy.
    Adelman M; Lyons AB; Seale L; Friedman BJ
    J Am Acad Dermatol; 2020 Apr; 82(4):e117-e119. PubMed ID: 31765681
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunohistochemical Profiling of Conjunctival Melanocytic Intraepithelial Lesions, Including SOX10, HMB45, Ki67, and P16.
    Milman T; Zhang Q; Ang S; Elder D; Lally SE; Shields JA; Hamershock RA; Sioufi K; Shields CL; Eagle RC
    Am J Ophthalmol; 2021 Feb; 222():148-156. PubMed ID: 33002486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRAME and Historical Immunohistochemical Antibodies Ki-67, P16, and HMB-45 in Ambiguous Melanocytic Tumors.
    Mert M; Bozdogan O; Bozdogan N; Gamsızkan M; Safali M
    Am J Dermatopathol; 2024 Oct; 46(10):653-662. PubMed ID: 38916203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferative Nodules vs Melanoma Arising in Giant Congenital Melanocytic Nevi During Childhood.
    Vergier B; Laharanne E; Prochazkova-Carlotti M; de la Fouchardière A; Merlio JP; Kadlub N; Avril MF; Bodemer C; Lacoste C; Boralevi F; Taieb A; Ezzedine K; Fraitag S
    JAMA Dermatol; 2016 Oct; 152(10):1147-1151. PubMed ID: 27486690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions.
    Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR
    Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of benign and malignant melanocytic lesions of the conjunctiva using double-staining.
    Soon AK; Brownstein S; Tang T; Saleh S; Jiang K; Levac J; Blanco P; Farmer J
    Can J Ophthalmol; 2019 Dec; 54(6):699-707. PubMed ID: 31836103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.
    Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V
    J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization.
    Busam KJ; Fang Y; Jhanwar SC; Pulitzer MP; Marr B; Abramson DH
    J Cutan Pathol; 2010 Feb; 37(2):196-203. PubMed ID: 20100177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence in situ hybridization (FISH) analysis of melanocytic nevi and melanomas: sensitivity, specificity, and lack of association with sentinel node status.
    Fang Y; Dusza S; Jhanwar S; Busam KJ
    Int J Surg Pathol; 2012 Oct; 20(5):434-40. PubMed ID: 22561674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.